Daiichi Sankyo today announced the appointment of Hiroyuki Okuzawa as its new global Chief Executive Officer (CEO), effective April 1, 2025. Mr. Okuzawa who currently serves as Representative ...

The trial aims to assess the safety and efficacy of Enhertu, either as a single agent or with pertuzumab, against the THP. AstraZeneca Plc (NASDAQ:AZN) on Monday released topline data from the ...

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally. The company offers Enhertu to treat patients with HER2 positive ...

Time magazine, naming Japanese actor Hiroyuki Sanada among its 100 most influential people in the world. Sanada was one of three Japanese who made the list, the others being musician Yoshiki and ...